Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Norway
Norway: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 95.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Norway, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Norway stood at 95.0%.
That represents a change of up 2.2% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Norway peaked at 96.0% in 2020 and was at its lowest, 86.0%, in 2008.
That places Norway 38th out of 194 countries with data for 2025, putting it in the top quarter.
The long-run direction has been consistently rising across the 18 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 88.5% | 86.0% | 91.0% | 2 |
| 2010s | 93.0% | 91.0% | 95.0% | 10 |
| 2020s | 95.3% | 95.0% | 96.0% | 6 |
Countries ranked near Norway
More health data for Norway
- Heat deaths vs projected death rates 1,212 (2090)
- Un projection of annual infant deaths 12 (2100)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 37,579 (2025)
- Age population, age 25, female, interpolated 35,248 (2025)
- Age population, age 24, male, interpolated 36,678 (2025)
- Age population, age 24, female, interpolated 34,677 (2025)
- Age population, age 23, male, interpolated 35,372 (2025)
- Age population, age 23, female, interpolated 33,935 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Norway?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Norway was 95.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Norway?
- The highest recorded value was 96.0% in 2020.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Norway?
- The lowest recorded value was 86.0% in 2008.
- How does Norway rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Norway ranks 38th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Norway?
- Over the last ten years it is up 2.2%. The long-run trend across the full record is rising.
- Where does this Norway data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).